
Rino Seedor
Assistant Professor · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Credentials: · · ·
History
Research
Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls
Ophthalmology · 2018 · 48 citations
Cancers · 2020 · First of 12 authors · 32 citations
Genetic Landscape and Emerging Therapies in Uveal Melanoma
Review · Cancers · 2021 · First of 3 authors · Corresponding · 28 citations

11 papers
- TS
8 papers
- RC
4 papers
- AS
3 papers

3 papers
- SK
3 papers

2 papers

2 papers
Clinical trials
- 2025–2032
Tebentafusp-tebn With LDT in Metastatic UM
Principal investigator · Recruiting · Phase 1, Phase 2
Thomas Jefferson University
- 2025–2032
Neoadjuvant Tebentafusp for Uveal Melanoma
Principal investigator · Recruiting · Phase 2
Thomas Jefferson University
- 2021–2024
Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma
Principal investigator · Terminated · Phase 2
Thomas Jefferson University
- 2024–2031
Site PI · Recruiting · Phase 3
Replimune, Inc.




